REQUEST A DEMO
Total
USD $0.00
Search more companies

Alborz Darou Pharmaceutical Company Public Joint Stock (البرز دارو للدواء المساهمة العامة) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Alborz Darou Pharmaceutical Company Public Joint Stock Profile Updated: March 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Alborz Darou Pharmaceutical Company Public Joint Stock (البرز دارو للدواء المساهمة العامة) is a company based in Iran, with its head office in Tehran. The company operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on April 04, 1976. It currently has a total number of 608 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 41.89% in 2025. Its’ total assets recorded a growth of 53.42%. The net profit margin of Alborz Darou Pharmaceutical Company Public Joint Stock (البرز دارو للدواء المساهمة العامة) increased by 2.98% in 2025.

Legal Address
Africa Blvd Not Reaching To Crossroad Jahaan Koodak, Navak Street - No. 3, Floor 5
Tehran; Tehran; Postal Code: 1518646177

Contact Details: Purchase the Alborz Darou Pharmaceutical Company Public Joint Stock (البرز دارو للدواء المساهمة العامة) report to view the information.

Website: http://www.alborzdarouco.com

Basic Information
Total Employees:
Purchase the Alborz Darou Pharmaceutical Company Public Joint Stock (البرز دارو للدواء المساهمة العامة) report to view the information.
Outstanding Shares:
Purchase the Alborz Darou Pharmaceutical Company Public Joint Stock (البرز دارو للدواء المساهمة العامة) report to view the information.
Financial Auditors:
Purchase the Alborz Darou Pharmaceutical Company Public Joint Stock (البرز دارو للدواء المساهمة العامة) report to view the information.
Incorporation Date:
April 04, 1976
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
60.22%
Purchase this report to view the information.
38.35%
Purchase this report to view the information.
5.34%
Purchase this report to view the information.
5.12%
Purchase this report to view the information.
3.15%
Subsidiaries
Pakhsh Alborz Company Public Joint Stock
4%
Etela Alborz Investment Company Public Joint Stock
3%
Kbc Company Public Joint Stock
0.14%
Company Performance
Financial values in the chart are available after Alborz Darou Pharmaceutical Company Public Joint Stock (البرز دارو للدواء المساهمة العامة) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
41.89%
Total Operating Revenue
41.76%
Operating Profit
61.8%
EBITDA
61.78%
Net Profit/Loss for the Period
60.05%
Total Assets
53.42%
Total Equity
65.22%
Operating Profit Margin
5.35%
Net Profit Margin
2.98%
Return on Equity (ROE)
-1.27%
Debt / Equity
-1698%
Quick Ratio
65.03%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?